P1.04-34 Study on Treatment of Stage IV Solid Tumors With Mutant Neoantigen Specific T Cells

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.749
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Making CAR T Cells a Solid Option for Solid Tumors

Frontiers in Immunology
AllergyImmunology
2018English

Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors

Cancer Discovery
Oncology
2015English

Regulatory T Cells Control Uveoretinitis Induced by Pathogenic Th1 Cells Reacting to a Specific Retinal Neoantigen

Journal of Immunology
AllergyImmunology
2006English

CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies

Frontiers in Immunology
AllergyImmunology
2018English

Late-Differentiated Effector Neoantigen-Specific CD8+ T Cells Are Enriched in Peripheral Blood of Non-Small Cell Lung Carcinoma Patients Responding to Atezolizumab Treatment

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

CAR-T Cells With Co-Expressed Cytokines and Chemokines Better Overcome Inhibitory Microenvironment of Solid Tumors

Clinical Research and Trials
2019English

P1.04-01 Impact of Chromatin Remodeling Genes Including SMARCA2 and PBRM1 on Neoantigen and Immune Landscape of NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

T Cells and T Cell Tumors Efficiently Generate Antigen-Specific Cytotoxic T Cell Immunity When Modified With an NKT Ligand

OncoImmunology
OncologyAllergyImmunology
2012English

US Food and Drug Administration Approves First Cancer Treatment for Any Solid Tumors With Specific Biomarker

Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy